Auricular Acupuncture in the Treatment of Obesity (AcupObesity)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02269371|
Recruitment Status : Completed
First Posted : October 21, 2014
Last Update Posted : December 12, 2016
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Other: Auricular Acupuncture Other: Sham Acupuncture||Phase 4|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||82 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Auricular Acupuncture in the Treatment of Obesity: a Randomized, Placebo-controlled, Trial|
|Study Start Date :||February 2015|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
Experimental: Group 1
Group 1: Standard of care weight loss intervention plus auricular acupuncture at Shen Men, Point Zero, and Appetite Control Point/Hunger Point in each ear.
Other: Auricular Acupuncture
Standard of care weight loss intervention plus auricular acupuncture at Shen Men, Point Zero, and Appetite Control Point/Hunger Point in each ear.
Other Name: acupuncture
Sham Comparator: Group 2
Group 2: Standard of care weight loss intervention plus sham acupuncture at three nonacupoints in each ear.
Other: Sham Acupuncture
Standard of care weight loss intervention plus sham acupuncture at three nonacupoints in each ear.
Other Name: sham
- greater weight loss [ Time Frame: 22 weeks ]As assessed by weight, waist circumference, and body mass index calculations
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02269371
|United States, Nevada|
|Mike O'Callaghan Federal Hospital/Nellis Air Force Base|
|Las Vegas, Nevada, United States, 89191|
|Principal Investigator:||Clinton Borchardt, MD||Mike O'Callaghan Federal Medical Center|